Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Hum Mutat ; 29(6): E27-36, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18429042

ABSTRACT

We characterized 29 unrelated patients presenting with the severe form of Pompe disease (Glycogen Storage Disease Type II, acid maltase deficiency) and identified 26 pathogenic mutations divided over 28 different genotypes. Among the eight new mutations, five were exonic point mutations (c.572A>G, c.1124G>T, c.1202A>G, c.1564C>G and c.1796C>A) leading to codon changes (p.Y191C, p.R375L, p.Q401R, p.P522A and p.S599Y); two were intronic point mutations (c.-32-3C>A and c.1636+5G>C) affecting mRNA processing; one was a single base deletion (c.742delC) generating a truncated protein (p.L248PfsX20). A comprehensive evaluation, based on different methodological approaches, confirmed the detrimental effect of the eight mutations on the protein and its function. Structural alterations potentially induced by the five missense mutations were also predicted through visual inspection of the atomic model of the GAA protein, in terms of both function and spatial orientation of specific residues as well as disturbance generated by amino acid substitutions. Although the remarkable heterogeneity of the mutational spectrum in Pompe disease was already known, our data demonstrate and confirm the power of molecular and functional analysis in predicting the natural course of Pompe disease.


Subject(s)
Glycogen Storage Disease Type II/genetics , Mutation , alpha-Glucosidases/genetics , Animals , COS Cells , Child, Preschool , Chlorocebus aethiops , DNA Mutational Analysis , Exons , Gene Deletion , Humans , Infant , Introns , Models, Molecular , Mutation, Missense , Point Mutation , alpha-Glucosidases/chemistry
2.
Clin Chim Acta ; 375(1-2): 136-9, 2007 Jan.
Article in English | MEDLINE | ID: mdl-16919251

ABSTRACT

Alpha-mannosidosis is a recessively inherited disorder due to the deficiency of the lysosomal alpha-mannosidase. We report the molecular analysis performed in two patients with the late onset form of alpha-mannosidosis. Four new alleles were identified: three missense mutations involving highly conserved residues, c.597 C>A (p.H200N), c.1553 T>C (p.L518P) and c.2746 C>A (p.R916S) and a single nucleotide deletion, c.2660delC. In vitro expression studies in COS-1 cells demonstrated that pH200N, p.L518P and p.R916S proteins are expressed but retained no residual enzyme activity. These data are supported by structural 3D analysis which predicted that both p.L518P and p.R916S could affect the interaction of the small E-domain with the active site domain or the main body of the structure while the pH200N might alter substrate binding or other catalytic properties. Finally, the c.2660delC causes a frameshift introducing a premature stop codon (p.T887SfsX45), presuming to be a severe mutation.


Subject(s)
Mutation , alpha-Mannosidase/genetics , alpha-Mannosidosis/genetics , Adult , Animals , COS Cells , Child , Chlorocebus aethiops , Female , Genotype , Humans , Male , Mutagenesis, Site-Directed , Protein Conformation , alpha-Mannosidase/chemistry , alpha-Mannosidase/metabolism , alpha-Mannosidosis/enzymology
3.
Hum Mutat ; 27(10): 999-1006, 2006 Oct.
Article in English | MEDLINE | ID: mdl-16917947

ABSTRACT

Glycogen storage disease type II (GSDII) is a recessively inherited disorder due to the deficiency of acid alpha-glucosidase (GAA) that results in impaired glycogen degradation and its accumulation in the lysosomes. We report here the complete molecular analysis of the GAA gene performed on 40 Italian patients with late onset GSDII. Twelve novel alleles have been identified: missense mutations were functionally characterized by enzyme activity and protein processing in a human GAA-deficient cell line while splicing mutations were studied by RT-PCR and in silico analysis. A complex allele was also identified carrying three different alterations in cis. The c.-32-13T > G was the most frequent mutation, present as compound heterozygote in 85% of the patients (allele frequency 42.3%), as described in other late onset GSDII Caucasian populations. Interestingly, the c.-32-13T > G was associated with the c.2237G > A (p.W746X) in nine of the 40 patients. Genotype-phenotype correlations are discussed with particular emphasis on the subgroup carrying the c.-32-13T > G/c.2237G > A genotype.


Subject(s)
Glycogen Storage Disease Type II/genetics , Mutation/genetics , alpha-Glucosidases/genetics , Adolescent , Adult , Age of Onset , Aged , Alleles , Blotting, Western/methods , Child , Child, Preschool , DNA Mutational Analysis/methods , Exons/genetics , Female , Fibroblasts/metabolism , Gene Frequency , Genotype , Glycogen Storage Disease Type II/epidemiology , Glycogen Storage Disease Type II/ethnology , Humans , Italy , Male , Middle Aged , Phenotype , alpha-Glucosidases/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...